Noninvasix Overview

  • Founded

  • 2007

Founded
  • Status

  • Private

  • Employees

  • 4

Employees
  • Latest Deal Type

  • Later Stage VC

  • (In Progress)
  • Latest Deal Amount

  • $1.8M

  • Investors

  • 14

Noninvasix General Information

Description

Developer of an optoacoustic platform technology designed to non-invasively and continuously measure central venous saturation. The company's technology monitors the severity of sepsis and septic shock and measures the amount of oxygen in the brain in real-time, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real-time.

Contact Information

Website
www.noninvasix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Care of University of Texas Medical Branch
  • 301 University Boulevard 2A
  • Galveston, TX 77555
  • United States
+1 (303) 000-0000

Noninvasix Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Noninvasix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 06-Dec-2021 $1.8M 00.000 In Progress Generating Revenue
8. Seed Round 18-Feb-2021 000 00.000 Completed Product Development
7. Seed Round 10-Jun-2020 00.000 00.000 0000 Completed Product Development
6. Angel (individual) 07-Jan-2019 Completed Startup
5. Grant 05-Aug-2018 00000 Completed Startup
4. Accelerator/Incubator 30-Nov-2016 Completed Startup
3. Accelerator/Incubator 05-Sep-2015 Completed Startup
2. Grant 03-Jun-2015 $6.32M Completed Startup
1. Accelerator/Incubator 10-Mar-2015 Completed Startup
To view Noninvasix’s complete valuation and funding history, request access »

Noninvasix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed 3 000,000 00.000000 00.0 00.0 00 00.0 0.000
Seed 2 000,000 00.000000 00.00 00.00 00 00.00 0.000
Seed 1 332,618 $0.001000 $1.02 $1.02 1x $1.02 3.4%
Seed 1,716,051 $0.001000 $1.22 $1.22 1x $1.22 17.53%
To view Noninvasix’s complete cap table history, request access »

Noninvasix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an optoacoustic platform technology designed to non-invasively and continuously measure central venous satu
Monitoring Equipment
Galveston, TX
4 As of 2022
00.000
0000000000 0 00.000

000 00

d exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in rep
0000000000 000000000
San Clemente, CA
00000 As of 0000
0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Noninvasix Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000 0000000 Corporation San Clemente, CA 00000 0000 000000000000
You’re viewing 1 of 1 competitors. Get the full list »

Noninvasix Executive Team (4)

Name Title Board Seat Contact Info
David Giarracco Chief Executive Officer & Board Member
Graham Randall Ph.D Chief Scientist and President
Donald Prough MD Co-Founder & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Noninvasix Board Members (7)

Name Representing Role Since
Daniel Parsley Self Board Observer 000 0000
David Giarracco Noninvasix Chief Executive Officer & Board Member 000 0000
Donald Prough MD Noninvasix Co-Founder & Board Member 000 0000
James Helliwell MD Self Board Member 000 0000
Lana Caron Self Board Observer 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Noninvasix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Noninvasix Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Philips Corporation Minority 000 0000 000000 0
Green Park & Golf Ventures Venture Capital Minority 000 0000 000000 0
Philips Electronics North America Corporation Pension Plan Limited Partner Minority 000 0000 000000 0
Springhood Venture Capital Minority 000 0000 000000 0
Texas Ventures PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial